These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34379047)

  • 41. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Vaccine; 2011 Jun; 29(28):4544-55. PubMed ID: 21549787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
    Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
    Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice.
    Charlier N; Molenkamp R; Leyssen P; Paeshuyse J; Drosten C; Panning M; De Clercq E; Bredenbeek PJ; Neyts J
    J Virol; 2004 Jul; 78(14):7418-26. PubMed ID: 15220415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
    Barba-Spaeth G; Longman RS; Albert ML; Rice CM
    J Exp Med; 2005 Nov; 202(9):1179-84. PubMed ID: 16260489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Completed sequences analysis on the Chinese attenuated yellow fever 17D vaccine strain and the WHO standard yellow fever 17D vaccine strain].
    Li J; Yu YX; Dong GM
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):145-51. PubMed ID: 20077661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
    Qian X; Wu B; Tang H; Luo Z; Xu Z; Ouyang S; Li X; Xie J; Yi Z; Leng Q; Liu Y; Qi Z; Zhao P
    Emerg Microbes Infect; 2022 Dec; 11(1):873-884. PubMed ID: 35249454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
    Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.
    Lefeuvre A; Contamin H; Decelle T; Fournier C; Lang J; Deubel V; Marianneau P
    Microbes Infect; 2006 May; 8(6):1530-8. PubMed ID: 16697681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.
    Thibodeaux BA; Garbino NC; Liss NM; Piper J; Schlesinger JJ; Blair CD; Roehrig JT
    Antiviral Res; 2012 Apr; 94(1):1-8. PubMed ID: 22366350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
    Engel AR; Vasconcelos PF; McArthur MA; Barrett AD
    Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles.
    Gandini M; Reis SR; Torrentes-Carvalho A; Azeredo EL; Freire Mda S; Galler R; Kubelka CF
    Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):594-605. PubMed ID: 21894381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.
    Douam F; Ploss A
    Trends Microbiol; 2018 Nov; 26(11):913-928. PubMed ID: 29933925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector.
    Galler R; Freire MS; Jabor AV; Mann GF
    Braz J Med Biol Res; 1997 Feb; 30(2):157-68. PubMed ID: 9239300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.
    McArthur MA; Xiao SY; Barrett AD
    Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Caine EA; Osorio JE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi.
    Nogueira RT; Nogueira AR; Pereira MC; Rodrigues MM; Neves PC; Galler R; Bonaldo MC
    PLoS One; 2013; 8(3):e59347. PubMed ID: 23527169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.